A new point-of-care test, Samsung IB B·R·A·H·M·S PCT: accurate sepsis diagnosis and antibiotic stewardship

As you can imagine, early diagnosis is key in preventing like early identification and treatment.

 

Henceforth, the Samsung IBB·R·A·H·M·S PCT a point-of-care (POC) immunoassay for the in vitro quantitative determination of Procalcitonin (PCT) in EDTA whole blood and plasma, which recently received a CE mark for use in Europe, may further improve medical decision-making about risk assessment and therapy management. 

As the first co-developed product by Thermo Fisher and Samsung Electronics, the Samsung IB B·R·A·H·M·S PCT test can enable fast and easy Procalcitonin determination in acute care settings as testing results in 20 minutes while providing portability and connectivity.